Bristol-Myers Squibb Co (BMY) stock is down -0.73% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives BMY stock a score of 68 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 88. BMY's rank also includes a short-term technical score of 62. The fundamental score for BMY is 55. In addition to the average rating from Wall Street analysts, BMY stock has a mean target price of $71.30. This means analysts expect the stock to increase 11.91% over the next 12 months.
BMY has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on BMY!
Bristol-Myers Squibb Co (BMY) stock is lower by -1.35% while the S&P 500 is down -1.12% as of 2:34 PM on Friday, Jan 21. BMY is down -$0.87 from the previous closing price of $64.58 on volume of 6,489,881 shares. Over the past year the S&P 500 is up 15.04% while BMY is down -0.73%. BMY lost -$2.40 per share in the over the last 12 months.
Click Here to get the full Stock Report for Bristol-Myers Squibb Co stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
